ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

ADMA Biologics faces a securities class action lawsuit alleging failure to disclose material information, including undisclosed related party transactions, channel stuffing, and inadequate internal controls. Investors with losses exceeding $100,000 have until August 10, 2026 to file lead plaintiff applications for securities purchased between August 9, 2024 and March 25, 2026.